title: Review of drugs for Alzheimer's disease.
abstract: Alzheimer's disease (AD) is the most common form of dementia in the elderly. The number of people affected by AD is rapidly increasing. AD is characterized by cerebral atrophy, cerebral senile plaques, intraneuronal neurofibrillary tangles, and neuronal cell loss. Medical treatment of AD has a long history and differing results. We will review the effectiveness and limitations of the drugs used to treat AD.
authors: Institute of Biochemical and Biotechnological Drugs, School of Pharmaceutical Science, Shandong University, Ji’nan, Shandong, China.
authors: Xiaoting
authors: X
authors: Sun
authors: Lan
authors: L
authors: Jin
authors: Peixue
authors: P
authors: Ling
mesh_terms: D000544:Alzheimer Disease / Q000188:drug therapy* / Q000209:etiology; D000595:Amino Acid Sequence; D016229:Amyloid beta-Peptides / Q000037:antagonists & inhibitors / Q000737:chemistry / Q000276:immunology / Q000502:physiology; D016564:Amyloid beta-Protein Precursor / Q000378:metabolism; D000818:Animals; D002800:Cholinesterase Inhibitors / Q000627:therapeutic use; D006801:Humans; D007114:Immunization; D008969:Molecular Sequence Data; D010275:Parasympathetic Nervous System / Q000187:drug effects / Q000503:physiopathology
chemical_list: D016229:Amyloid beta-Peptides; D016564:Amyloid beta-Protein Precursor; D002800:Cholinesterase Inhibitors